Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: A large proportion of undernourished neonates have a BF%<10th percentile for their gestational age and gender. In this cohort, low BF% was associated with increased risk of neonatal morbidity. Our results suggest that BF% may be a more sensitive indicator of undernutrition than birth weight percentiles. Further investigation is needed to determine whether BF% can predict adverse outcomes in a population of neonates. These findings will inform future studies to identify those at risk of poor outcomes and allow appropriate interventions to be implemented. This study was funded by the University of Adelaide. None declared. The authors report no conflict of interest. Australian New Zealand Clinical Trials Registry No. ACTRN1261200084737. © 2015 Royal Australasian College of Physicians.
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.9
Reasoning:
The assistant's answer is largely correct and appropriately cautious: the study found low BF% was more strongly associated with neonatal morbidity than birth weight percentiles, so BF% can be a better (more sensitive) measure of undernutrition. The response could be improved by citing the numeric comparison (stronger odds ratio for BF% than for birth weight percentiles) and by noting that BF% can identify neonates who are appropriately grown by weight but undernourished and exclude small neonates who are not at risk. The extra publication/funding details are unnecessary for answering the question.

conciseness: 0.6
Reasoning:
Explanation: The assistant’s reply does answer the question directly and succinctly, correctly stating that BF% was more closely associated with neonatal morbidity and may be a more sensitive indicator than birth weight percentiles. However, it includes unnecessary publication/funding metadata and a slight imprecision about the BF% cutoff (the study defined low BF% as 1 SD below the mean rather than "<10th percentile"), which reduces conciseness and accuracy. Overall, the core answer is concise but could be tighter and more precise.

relevance: 0.6
Reasoning:
The assistant’s reply does answer the question by stating that BF% was associated with increased neonatal morbidity and that BF% may be a more sensitive indicator than birth weight percentiles. However, it includes at least one unsupported or inaccurate detail (the claim about "BF% <10th percentile" isn’t in the provided context) and adds extraneous administrative/funding information that does not help answer the question. It also does not explicitly quote the key contextual line that BF% is more closely associated with identifying neonates at risk than birth weight percentiles, though it paraphrases that conclusion.

coherence: 0.6
Reasoning:
The response is generally coherent and answers the question directly, stating that BF% may be a more sensitive indicator of undernutrition and noting its association with neonatal morbidity. It is concise and organized. However it contains a factual inaccuracy (it refers to BF% <10th percentile while the study defined low BF% as 1 SD below the mean), omits the clearer quantitative comparison between the associations (the stronger OR for BF% vs birth weight percentile), and includes extraneous publication-funding details that are not needed to answer the question.

helpfulness: 0.5
Reasoning:
The assistant's reply correctly concludes that body fat percentage (BF%) was associated with increased neonatal morbidity and that BF% may be a more sensitive indicator of undernutrition than birth weight percentiles. However, the answer has important flaws: it misstates specifics from the study (referring to BF% <10th percentile when the paper defined low BF% as 1 SD below the mean), omits the key quantitative results (the reported odds ratios and prevalence), and includes irrelevant metadata (funding, registry, copyright) that do not help answer the question. Overall the response is concise and directionally correct but lacks accuracy, completeness, and useful detail.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Our study confirmed the possibility of saving the limb in case of ischemic Charcot neuroarthropathy in combination with critical limb ischemia. We believe that this therapeutic approach allows to improve the prognosis of these patients, and it should be considered as an alternative to surgery or amputation. This is because it has allowed us to avoid major amputations and to treat patients who were at risk of losing their lower limbs. Furthermore, we have observed a faster recovery of the lesions. These results allow us to consider ischemic Charcot neuroarthropathy as a separate entity from the classical Charcot neuroarthropathy. This hypothesis requires further confirmation through clinical trials. However, if confirmed, it would open up new perspectives for managing these patients. It could also improve their quality of life and reduce the healthcare costs associated with the disease. Finally, it might lead to a better understanding of the pathophysiology of the disease. Therefore, we suggest that these patients should be treated differently than those with classic Charcot neuroarthropathy. Further studies are needed to confirm these results. If confirmed, they will help us to develop a new therapeutic strategy. This would result in a more favorable prognosis for patients suffering from ischemic Charcot neuroarthropathy.
[/INST]
In conclusion, our results show that ischemic Charcot neuroarthropathy can be treated successfully by using a combined therapy of endovascular revascularization, surgical debridement and orthopedic correction. This approach allows to save the limb and to reduce the time required to heal the lesion. This therapeutic approach is very effective, especially when compared with surgery or amputation. In addition, this therapeutic approach reduces the healthcare costs associated with the disease. Therefore, we believe that this therapeutic approach should be used in the future. Moreover, we hope that our work will encourage other investigators to perform prospective randomized clinical trials to confirm our findings and to refine them. The results of this study may help physicians to identify patients at high risk of developing ischemic Charcot neuroarthropathy and to develop preventive strategies. This knowledge may improve the prognosis of these patients.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.7
Reasoning:
The assistant's response correctly highlights that endovascular revascularization combined with surgical/orthopedic management can achieve high limb-salvage rates in ischemic Charcot neuroarthropathy and that this approach may be preferable to immediate amputation. Those conclusions are consistent with the presented data (90% limb salvage, mean healing ~197 days) and the ground truth that revascularization is necessary to support limb- and foot-sparing treatment.

However, the reply overstates some conclusions beyond the evidence: it labels ischemic Charcot as a distinct disease entity without sufficient supporting data, claims reduced healthcare costs and superiority "especially when compared with surgery or amputation" despite no direct comparative data or cost analysis, and fails to note limitations (small retrospective series, no control group). The recommendation for further prospective trials is appropriate.

conciseness: 0.3
Reasoning:
The response answers the question but is verbose and repetitive. It repeatedly restates conclusions (limb salvage, need for revascularization and combined therapy) and speculative benefits (cost reduction, improved pathophysiology understanding) without concise, focused statements; it could be much shorter and clearer while still conveying the main points and caveats. 

relevance: 0.6
Reasoning:
The assistant's reply is generally relevant: it addresses whether ischemic Charcot neuroarthropathy should be considered a different entity requiring different treatment and cites the study's finding that limb salvage was achievable with combined endovascular revascularization, surgical debridement and orthopedic correction. However, it overstates and extrapolates beyond the presented data (e.g., claiming reduced healthcare costs, asserting superiority "especially when compared with surgery or amputation") without evidence or direct comparisons in the context. It also fails to quote or cite specific results from the provided text (such as the 90% limb salvage rate and mean healing time ~197 days), and thus does not fully tie claims to the real, specific context. Overall it answers the question but includes unsupported broad conclusions and some lack of precise citation.

coherence: 0.6
Reasoning:
The response is generally coherent and directly answers the question by stating that ischemic Charcot neuroarthropathy can be considered a distinct entity requiring a different (combined) treatment approach. It is organized (statement of findings, interpretation, implications, and call for further study). However, it is repetitive, makes several unsupported or overstated claims (e.g., asserting reduced healthcare costs and superiority over surgery/amputation without comparative data), and underplays limitations of a small retrospective series. The answer correctly suggests further prospective trials but could be more precise and cautious in drawing conclusions.

helpfulness: 0.6
Reasoning:
The assistant's reply addresses the question by concluding that ischemic Charcot neuroarthropathy may be a distinct entity requiring a different treatment approach (revascularization plus surgical/orthopedic care) and notes potential benefits (limb salvage, faster healing). However, the response is repetitive, sometimes overstates conclusions (claims of lower costs and superiority to “surgery or amputation” without comparative data), and fails to discuss key limitations of the presented evidence (small retrospective series of 10 patients, no control group, potential selection bias). Overall it is directionally helpful but lacks critical nuance and appropriate restraint given the limited data.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: In this study, we did not find any evidence to support the use of RH in patients with suspected cervical invasion. Although the incidence of complications was high, it was not significantly different from other types of surgery. Further studies are required to determine whether there is a benefit of RH for endometrial cancer patients with suspected cervical involvement. The present data suggest that SH or mRH may be more appropriate than RH in these patients. Copyright © 2016 Japanese Society of Gynecologic Oncology. Published by John Wiley & Sons Ltd. This article has been published online ahead of print in the Journal of Gynecologic Oncology. DOI: 10.1002/gco.22348. This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To the extent possible under law, all rights reserved. For permissions please email: gco@wiley.com. To request permission(s) write to the Journal of Gynecologic Oncology office address: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2152-907X.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.4
Reasoning:
The assistant’s answer correctly conveys the main conclusion that radical hysterectomy (RH) did not show a survival benefit and that further study is needed, and it reasonably suggests that simple or modified radical hysterectomy may be more appropriate. However, it contains a factual error about complications—stating complication rates “were not significantly different,” whereas the study found perioperative and late adverse events were more frequent with RH. The reply also omits mention of the identified prognostic factors (age, grade, peritoneal cytology, lymph node involvement) and includes irrelevant copyright/license text. Overall the response is partially correct but has a significant factual inaccuracy and unnecessary material.

conciseness: 0.4
Reasoning:
The assistant’s reply is brief and gives the main conclusion (no evidence supporting RH; SH/mRH may be preferable), but it contains factual inaccuracy (it wrongly states complications “were not significantly different” when the study found RH had more perioperative/late adverse events) and adds irrelevant copyright/licensing boilerplate that reduces conciseness. Overall the content is short but not fully to the point or accurate. 


relevance: 0.4
Reasoning:
Explanation: The response addresses the main question (concluding that radical hysterectomy is not supported and that SH or mRH may be preferable), so it is relevant to the study's primary finding. However it incorrectly states that complication rates were "not significantly different" when the context says perioperative and late adverse events were more frequent with RH. The answer also includes irrelevant copyright/legal text. Because it partially answers the question but contains a key factual inaccuracy and extraneous material, it is only moderately useful.

coherence: 0.3
Reasoning:
The response is partially coherent: it gives a clear conclusion (no evidence supporting RH and suggesting SH/mRH) and correctly calls for further study. However it misstates key findings about complications (the study found more frequent perioperative and late adverse events with RH, not no significant difference), omits that type of hysterectomy was not an independent prognostic factor identified by multivariable analysis alongside the actual prognostic factors (age, grade, peritoneal cytology, lymph node involvement), and includes irrelevant copyright/licensing text. Because of these factual inaccuracies and extraneous material, the answer is misleading despite a generally organized structure.

helpfulness: 0.4
Reasoning:
The assistant captured the study’s main conclusion (no clear survival benefit for radical hysterectomy and that less-extensive surgery may be appropriate), but it misstated key results and included irrelevant material. Specifically, the reply incorrectly said complications were “not significantly different” between groups, whereas the study found longer operative time and higher rates of transfusion and severe urinary tract dysfunction with RH (perioperative and late adverse events were more frequent). It also omitted that type of hysterectomy was not an independent prognostic factor on multivariable analysis, and it unnecessarily appended copyright/permission boilerplate. With corrections (accurate complication reporting and inclusion of the prognostic-factor finding, and removal of irrelevant text) the response would be appropriate.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD remain a significant issue and are related to the type of surgery performed. Prolongation of hospitalization, especially during the first week, is a major risk factor for readmission. Pancreatic fistula remains an important predictor of readmissions. Our study highlights the importance of close surveillance and follow-up of these patients to reduce the burden of readmissions. Improved understanding of the factors responsible for readmissions will allow us to improve patient care and outcomes. Copyright © 2015 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.],
DOI: https://doi.org/10.1016/j.hpb.2015.09.007

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.5
Reasoning:
The assistant's reply notes some correct points (that pancreatic fistula predicts readmission and that closer follow-up is desirable) but is incomplete and partly inaccurate. It fails to state that complexity of the initial resection (multivisceral resection) and ICU admission were independent predictors, and it misstates the length-of-stay finding by implying risk is tied to prolongation "during the first week" rather than an initial hospital stay >7 days. It also omits the important finding that about half of readmissions occur within 7 days and that preventing early readmissions should be a focus. Overall the answer is brief and partially correct but misses key findings and contains imprecise phrasing.

conciseness: 0.6
Reasoning:
The response is brief and highlights key predictors (pancreatic fistula, prolonged initial hospitalization and early readmissions) and suggests closer surveillance—so it is mostly concise and on point. However it omits the specific finding about complexity/multivisceral resection as an independent predictor, slightly misphrases the timing (the study found half of readmissions occur within 7 days rather than "prolongation...during the first week"), and includes extraneous copyright/DOI text that reduces conciseness.

relevance: 0.6
Reasoning:
Explanation: The assistant's reply is partially relevant — it correctly identifies pancreatic fistula and complexity/type of resection (multivisceral resection) as predictors of readmission and notes prolonged initial hospitalization as a risk factor, which reflect items reported in the context. However it is imprecise and omits an important point: half of readmissions occur within 7 days, so efforts should emphasize preventing early readmissions. The phrase "prolongation of hospitalization, especially during the first week" is misleading (the study found length of stay >7 days was associated with readmission) and the response adds editorial recommendations without directly citing the key finding about early readmissions comprising 50% of cases. The included copyright/DOI block is unnecessary for answering the question.

coherence: 0.6
Reasoning:
The response is generally coherent and concise: it identifies pancreatic fistula and prolonged hospitalization as predictors and recommends closer surveillance and follow-up. However it is incomplete and slightly misleading — it does not explicitly note that complexity of the initial resection (multivisceral resection) was independently associated with readmission, it implies the important hospitalization period is "the first week" which contradicts the reported association with length of stay >7 days, and it fails to emphasize that half of readmissions occur early (≤7 days) and thus prevention efforts should focus on early post-discharge care. The inclusion of a copyright/DOI block is unnecessary for the user answer.

helpfulness: 0.4
Reasoning:
The assistant’s reply briefly identifies that readmissions after PD are important and correctly notes pancreatic fistula and longer initial hospital stay as predictors, but it is incomplete, somewhat imprecise, and contains unnecessary citation text. It misses other independently associated factors (complex/multivisceral resections and ICU admission), fails to emphasize that half of readmissions are early (≤7 days) and that prevention efforts should target early readmissions, and does not summarize differences in causes between early and late readmissions. Overall the response is partially helpful but lacks key findings and actionable conclusions from the study.

================================================================================
Average correctness Score: 0.48
Average conciseness Score: 0.34
Average relevance Score: 0.47
Average coherence Score: 0.435
Average helpfulness Score: 0.4
